(Q44698041)

5 December 2017

title

Interaction between fibrates and statins--metabolic interactions with gemfibrozil (English)

1 reference

5 December 2017

0 references

Hideki Fujino

1

1 reference

5 December 2017

Iwao Yamada

2

1 reference

5 December 2017

Shimada Shimada

3

1 reference

5 December 2017

Masaru Hirano

4

1 reference

5 December 2017

Yoshihiko Tsunenari

5

1 reference

5 December 2017

Junji Kojima

6

1 reference

5 December 2017

publication date

1 January 2003

1 reference

Drug Metabolism and Drug Interactions

5 December 2017

published in

1 reference

5 December 2017

volume

19

1 reference

5 December 2017

issue

3

1 reference

5 December 2017

page(s)

161-176

1 reference

NK-104: a novel synthetic HMG-CoA reductase inhibitor

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2003.19.3.161

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2003.19.3.161

Withdrawal of cerivastatin from the world market

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2003.19.3.161

Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2003.19.3.161

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FDMDI.2003.19.3.161

10.1515/DMDI.2003.19.3.161

21 January 2018

Identifiers

DOI

1 reference

5 December 2017

1 reference